StockComparison Logo
vs

EQIX vs GSK

Comparison between Equinix Inc (EQIX, Company) and GSK Plc (GSK, Company).

EQIX is from the Real Estate sector, while GSK is from the Healthcare sector.

5-Year PerformanceEQIX has outperformed GSK, delivering a return of +8.7% compared to +5.4%

EQIX vs GSK - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
EQIX
$106B
GSK
$105B
Max Drawdown
EQIX
99.44%
Winner
GSK
64.03%
Sharpe Ratio
EQIX
0.73
Winner
GSK
1.00
5Y Beta
EQIX
0.67
Winner
GSK
0.24
Industry
EQIX
Reit - Specialty
GSK
Drug Manufacturers - General
P/E Ratio
EQIX
73.94
Winner
GSK
12.14
Forward P/E
EQIX
60.61
Winner
GSK
10.44
PEG Ratio
EQIX
1.46
Winner
GSK
0.10
Dividend Yield
EQIX
1.77%
Winner
GSK
3.51%
5Y Dividends CAGR
Winner
EQIX
17.14%
GSK
1.34%
5Y EPS CAGR
Winner
EQIX
25.92%
GSK
4.65%
Debt to Equity
EQIX
138.38%
Winner
GSK
106.74%
Free Cash Flow Yield
EQIX
3.62%
Winner
GSK
8.01%
P/S Ratio
EQIX
11.08
Winner
GSK
3.16
P/B Ratio
EQIX
7.38
Winner
GSK
4.30

EQIX vs GSK - Historical Returns

Returns include dividend reinvestment.

1M
EQIX
+0.72%
Winner
GSK
+3.08%
3M
Winner
EQIX
+13.98%
GSK
-6.04%
6M
Winner
EQIX
+47.26%
GSK
+8.15%
1Y
EQIX
+21.50%
Winner
GSK
+29.75%
5Y(CAGR)
Winner
EQIX
+8.70%
GSK
+5.40%
10Y(CAGR)
Winner
EQIX
+13.51%
GSK
+4.36%
Max(CAGR)
Winner
EQIX
+4.97%
GSK
+3.12%

EQIX vs GSK - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearEQIXGSK
2026+42.91%+5.49%
2025-16.99%+50.62%
2024+18.70%-6.27%
2023+23.98%+9.25%
2022-20.22%-32.73%
2021+24.03%+23.62%
2020+25.16%-17.52%
2019+70.08%+30.36%
2018-19.29%+9.29%
2017+28.71%-3.80%
2016+23.27%+1.52%
2015+42.43%+0.48%
2014+34.71%-14.73%
2013-17.47%+26.97%
2012+103.67%-0.75%
2011+21.50%+22.51%
2010-25.83%-3.72%
2009+84.42%+20.27%
2008-46.07%-21.93%
2007+34.08%-2.77%
2006+82.52%+6.93%
2005-5.69%+9.96%
2004+48.25%+5.08%
2003+438.36%+25.04%
2002-93.38%-22.83%
2001-18.54%-9.58%
2000-66.62%+5.67%
1999N/A-5.78%

EQIX vs GSK Drawdown Comparison

The maximum drawdown for EQIX was -99.44%, occurring on Apr 10, 2003. Recovery took 4255 trading sessions.

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The current EQIX drawdown is -2.61%. The current GSK drawdown is -14.42%.

RankEQIXGSK
#1-99.44%
Aug 31, 2000 - Aug 2, 2017
-50.11%
Apr 13, 2022 - Jan 6, 2026
#2-41.77%
Sep 3, 2021 - Feb 8, 2024
-49.64%
Apr 20, 2007 - Apr 18, 2012
#3-29.35%
Nov 8, 2017 - May 6, 2019
-45.23%
Apr 25, 2000 - Nov 11, 2005
#4-28.19%
Oct 12, 2020 - Jul 7, 2021
-32.56%
Jan 17, 2020 - Dec 10, 2021
#5-25.12%
Feb 21, 2020 - Apr 8, 2020
-27.97%
Mar 4, 2014 - Sep 3, 2019
#6-24.59%
Dec 6, 2024 - Feb 25, 2026
-26.98%
Nov 5, 1999 - Apr 11, 2000
#7-24.18%
Mar 4, 2024 - Oct 25, 2024
-18.61%
Feb 18, 2026 - Jun 2, 2026
#8-20.61%
Aug 21, 2000 - Aug 31, 2000
-14.45%
Jan 18, 2022 - Apr 7, 2022
#9-10.38%
Sep 26, 2019 - Dec 27, 2019
-10.52%
May 16, 2006 - Feb 13, 2007
#10-8.62%
Sep 2, 2020 - Oct 7, 2020
-10.48%
Oct 4, 2012 - Mar 22, 2013
#11-8.54%
Aug 11, 2000 - Aug 18, 2000
-8.45%
May 28, 2013 - Nov 1, 2013
#12-8.43%
Sep 11, 2017 - Nov 2, 2017
-8.43%
Apr 11, 2000 - Apr 25, 2000
#13-7.83%
Apr 27, 2020 - Jun 1, 2020
-8.16%
Nov 11, 2005 - Mar 8, 2006
#14-7.70%
Jul 10, 2019 - Aug 7, 2019
-7.54%
Feb 14, 2007 - Apr 16, 2007
#15-6.97%
Jun 1, 2020 - Jun 19, 2020
-7.37%
Jan 21, 2014 - Feb 13, 2014

Correlation

Correlation between EQIX and GSK is 0.81 which considered as a strong positive correlation - the stocks tend to move together.

0.81
-101

Dividend Comparison (2000 - 2026)

EQIX vs GSK dividend yield comparison.

YearEQIXGSK
20260.95%1.72%
20252.45%3.42%
20241.81%4.60%
20231.80%3.75%
20221.89%5.47%
20211.36%4.99%
20201.49%5.59%
20191.69%4.35%
20182.59%5.65%
20171.77%5.83%
20161.96%6.86%
20155.86%5.93%
20143.34%6.20%
20130.00%4.51%
20120.00%5.70%
20110.00%4.83%
20100.00%5.10%
20090.00%4.39%
20080.00%5.74%
20070.00%4.09%
20060.00%3.29%
20050.00%3.03%
20040.00%3.38%
20030.00%2.77%
20020.00%3.10%
20010.00%1.54%
20000.00%4.57%

Select Stocks to Compare